The timely secretion of gonadal sex steroids is essential for the initiation of puberty, the postpubertal maintenance of secondary sexual characteristics and the normal perinatal development of male external genitalia. Normal gonadal steroid production requires the actions of the pituitary-derived gonadotropins, luteinizing hormone and follicle-stimulating hormone. We report four human pedigrees with severe congenital gonadotropin deficiency and pubertal failure in which all affected individuals are homozygous for loss-offunction mutations in TAC3 (encoding Neurokinin B) or its receptor TACR3 (encoding NK3R). Neurokinin B, a member of the substance P-related tachykinin family, is known to be highly expressed in hypothalamic neurons that also express kisspeptin 1 , a recently identified regulator of gonadotropinreleasing hormone secretion 2 . These findings implicate Neurokinin B as a critical central regulator of human gonadal function and suggest new approaches to the pharmacological control of human reproduction and sex hormone-related diseases.
The hallmark of sexual maturity is secretion from the pituitary gland of the gonadotropins luteinizing hormone and follicle-stimulating hormone, which act together, in gonadal tissue, to drive both sex hormone secretion and gametogenesis 3 . The production of luteinizing hormone and follicle-stimulating hormone from pituitary gonadotrope cells is largely controlled by the pulsatile delivery of gonadotropin releasing hormone (GnRH) from a functionally interconnected group of secretory neurons whose cell bodies are located predominantly in the medial basal hypothalamus in humans 3 . This complex central neuroendocrine regulatory unit is susceptible to negative feedback regulation from the gonads by sex steroids 3 , and although other physiological regulators have been proposed, there is considerable uncertainty about the relative importance and species specificity of many of these inputs 4 . Physiological positive regulators have been less readily identified. The gonadal endocrine system is active in utero and for the first few months of life, before entering a state of quiescence. The reactivation of the GnRH pulse generating system is the earliest detectable event at puberty, but the mechanisms subserving the central suppression and then rekindling of this system at puberty are an enduring enigma of human biology 5 .
Recently, through a combination of human and mouse genetics, the hypothalamically expressed peptide kisspeptin and its receptor GPR54 have been established to be necessary for normal GnRH secretion and thus gonadotrope function 6, 7 . Human genetics has been a powerful contributor to the discovery of critical molecular elements of the central control of reproduction, identifying several molecules that are essential for the embryonic migration of GnRH neurons to the hypothalamus from the olfactory placode (KAL1, NELF, FGFR1, PROK1, PROKR2). Humans with genetic defects in those molecules generally present clinically with failure to enter puberty and low circulating gonadotropin levels (hypogonadotropic hypogonadism) associated with impairment of olfactory sensation. Mutations either in the GnRH receptor or in GPR54 have been reported in humans with familial hypogonadotropic hypogonadism but normal olfaction (so-called normosmic idiopathic hypogonadotropic hypogonadism (nIHH)). However, these genetic defects explain only a minority of cases of familial nIHH 8 , implying the existence of other, as yet unknown, key positive regulators of the central control of the reproductive axis. Through genetic studies in consanguineous families with nIHH from Turkey, we establish that the tachykinin Neurokinin B (NKB), acting through its receptor NK3R, is an essential such regulator.
Nine consanguineous families not knowingly related to one another with multiple members affected by nIHH were subjected to genome-wide SNP analysis, and within each family we identified 9 regions of homozygosity common to all affected individuals but not found in unaffected. In three families (Fig. 1a) , homozygosity at a locus on the long arm of chromosome 4 segregated with nIHH.
Alignment of all six affected members of the three families refined the crucial interval to a 2.74 MB genomic region extending from 102.20 to 104.94 MB encompassing 20 known or predicted genes (Fig. 1b) . Of those genes, we selected TACR3 for further analysis. TACR3 encodes NK3R, the receptor for NKB, a tachykinin peptide known to be highly expressed in hypothalamic neurons that also express kisspeptin 1 . Synthetic NK3R agonists have also been reported to modulate reproductive function, but the site, and indeed direction, of such actions have been unclear 10, 11 . We found homozygous nonsynonymous mutations in the coding sequence of TACR3 in all affected subjects (and no unaffected subjects) in all three families (Supplementary Note and Supplementary Fig. 1 online) . In family 1, all affected individuals were homozygous for a G to A transversion at cDNA nucleotide 278. This mutation leads to the substitution of glycine at residue 93 for aspartic acid (G93D). Gly93 lies in the first transmembrane domain of the G protein-coupled NK3R (Fig. 1c) , and, although this residue is not highly conserved (Fig. 1d) , introduction of a negatively charged side chain in this very hydrophobic domain is likely to be highly thermodynamically unfavorable. Indeed, only 1 of 739 members of the rhodopsin receptor superfamily has a charged side chain at this position. In families 2 and 3, a C to T transition at cDNA nucleotide 1057 was found, producing a proline to serine change at residue 353 (P353S), which lies within the sixth transmembrane domain (Fig. 1c) . Pro353 is highly conserved (Fig. 1d) : 735 out of 739 members of the rhodopsin receptor superfamily have a proline at this position. Neither of these mutations was found in 100 ethnically matched (Turkish for family 1 and Kurdish for families 2 and 3) controls, in the 6 other families from the original genome-wide SNP analysis, nor in 50 individuals with nIHH from a variety of ethnic groups. In one multiplex family in which TACR3 mutations had been excluded (Fig. 2a) , we identified two autozygous regions that were common to the two affected family members but not to their unaffected sister. Although these regions-from 125.7 to 130.4 MB on chromosome 4 and 54.5 to 57.6 MB on chromosome 12-encompassed 21 and 102 known Il-2 Il-3 Il-4 or predicted genes respectively, the only obvious biologically plausible candidate was TAC3, on chromosome 12 ( Fig. 2a) , encoding NKB, the preferred ligand for the neurokinin-3 receptor. On sequencing TAC3, we identified a homozygous T to C transversion at cDNA nucleotide 269 in both affected siblings, leading to substitution of methionine by threonine at residue 90 (M90T) of the prohormone (Fig. 2b) . The parents and unaffected sister were heterozygous for the mutation, which was not detected in 100 Turkish controls. Met90 is the C-terminal amino acid of the mature NKB decapeptide, and it falls within the canonical tachykinin motif, Phe-Xaa-Gly-Leu-Met-NH 2 , which is universally conserved among known tachykinins 12 (for example, Fig. 2c ).
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In vivo, NKB is known to be post-translationally modified by C-terminal amidation, which has been shown to be necessary for full activity of the closely related neurokinin A peptide 13 . TACR3 activation is linked to G q proteins, and its action results in an increase in intracellular calcium. To evaluate the functional consequences of the TACR3 mutations, we expressed wild-type and mutant TACR3 in HEK293 cells and assessed the ability of NKB to stimulate calcium flux. In transiently transfected cells, identified on the basis of coexpressed green fluorescent protein (GFP), NKB elicited a robust increase in intracellular calcium, with an effector concentration for half-maximum response (EC 50 ) of 6.6 ± 1.3 nM, whereas no response to NKB was seen in untransfected cells (Fig. 3) . Both G93D and P353S mutant receptors showed markedly attenuated ability to respond to stimulation, with EC 50 values for NKB of 290 ± 146 nM and 4.0 ± 2.1 µM respectively. Thus, both of the missense TACR3 mutations found in all affected subjects in families 1 through 3 show unequivocal evidence of impaired receptor signaling.
To assess the activity of the M90T variant NKB found in family 4, we synthesized the corresponding mature decapeptide in both C-terminal-amidated and non-amidated form and assessed the effects of each peptide on wild-type receptor, using the same heterologous expression system. The amidated mutant peptide (predicted to be the form that would occur in nature) had markedly reduced activity, being around tenfold less potent than amidated wild-type NKB at stimulating the NK3R (M90T EC 50 = 52 ± 6 nM; Fig. 4) . As expected, the non-amidated mutant NKB had little detectable ability to elicit calcium flux (data not shown).
The detailed phenotypes of subjects homozygous for either TAC3 or TACR3 mutations provided strong evidence that NKB, acting through its receptor NK3R, is essential for the central hormonal control of human reproduction (Supplementary Note and Supplementary Table 1 online). All subjects who were in the second decade of life or older showed unequivocal evidence of failure of pubertal progression with low circulating sex steroids and prepubertal levels of circulating gonadotropins. Furthermore, all affected males had micropenis, strongly suggesting failure of normal intrauterine and perinatal activation of the reproductive axis 14 . The only homozygote (out of nine) in any of the four families who did not yet show a clear phenotype was a 5-year-old female, in whom hypogonadotropic hypogonadism would not be expected to have become overt.
NK3R is widely expressed, particularly in the central nervous system 15 , and previous studies in rodents using pharmacological or genetic manipulation have suggested potential roles in a wide range of CNS functions 16, 17 . Additionally, polymorphisms in the TACR3 locus have been weakly genetically associated with a range of human neurobehavioral phenotypes 18 . In this regard, it is notable that subjects with homozygous loss of function mutations in TACR3 lacked any other clear neurobehavioral or other phenotypic abnormalities outside the reproductive axis. However, both affected subjects with TAC3 mutations did have mild learning disability (Supplementary Note), suggesting that NKB action, possibly through receptors other than NK3R, may have effects on higher cognitive function.
The precise mechanism whereby NKB and the NK3R exert their effects on the central neuroendocrine control of reproduction remains to be established. It is most likely, however, that this effect is exerted at the level of hypothalamic GnRH release. NK3R is expressed on rodent GnRH-expressing neurons 19, 20 . Axons of neurons expressing NKB are closely anatomically apposed to those of GnRH neurons within the median eminence of the hypothalamus 19, 21 , and NKB immunoreactive varicosities have been reported to be in direct contact with GnRH immunoreactive axons 22 . NKB expression is highest in the arcuate nucleus, where it colocalizes with estrogen receptor-α and dynorphin 23 , implicated in progesterone feedback to GnRH secretion 24 . NK3R and NKB nevertheless are also expressed in peripheral organs including ovaries and uterus 25 , so further peripheral effects cannot be formally excluded. However, there is a paucity of pharmacological or mouse genetic evidence directly implicating NKB or NK3R in gonadal function. Mice with genetic ablation of Tac2 (the murine ortholog of TAC3) have not been described, and studies of Tacr3 −/− mice have not reported a reproductive phenotype 17, 26, 27 . Notably, central administration of a potent NK3R agonist to ovariectomized, estrogen-primed rats suppressed luteinizing hormone R3HDM2  STAC3  NDUFA4L2  SHMT2  NXPH4  LRP1  STAT6  NAB2  TMEM194  MYO1A  TAC3  ZBTB39  GPR182  RDH16 Light blue, polar residues; dark blue, hydrophobic residues; lilac, negatively charged residues; pink, positively charged residues. a b c production rather than stimulating it 10 . It thus remains possible that there is true divergence in the reproductive role of the NKB/NK3R system between humans and rodents. In summary, we have identified loss-of-function mutations in either NKB or its receptor in four out of nine multiplex families affected by hypogonadotropic hypogonadism. These findings establish that NKB action through the NK3R is necessary for the central neuroendocrine control of human reproduction. These families represent the first examples of inherited defects of tachykinin signaling in any human disorder and our results suggest that the NKB/NK3R system may provide a new avenue for the pharmacological manipulation of human fertility and the treatment of sex steroid-related diseases, such as cancers of the breast and prostate.
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METHODS
The ethics committee of the Cukurova University Faculty of Medicine approved this study, and full informed consent was obtained for each participant. nIHH was defined by conventional criteria (Supplementary Methods online) . Normal karyotypes were confirmed and mutations in GNRHR, GNRH1, GPR54, KISS1, KAL1, NELF, PROK2, PROK2R and FGFR1 genes were ruled out by sequencing. Genome-wide SNP analysis used 250K NspI SNP microarrays (Affymetrix) and we analyzed data using AutoSNPa software 9 . PCR-amplified exons and splice junctions of TAC3 or TACR3 were sequenced on an ABI PRISM 3130 autosequencer (Applied Biosystems). For primer sequences and annealing temperatures, see Supplementary Table 2 online.
Wild type or mutant TACR3 in pIRES2-AcGFP1 (Clontech) were transfected into HEK293A cells (QBiogene) using polyethylenimine (Sigma) before seeding cells into poly-l-lysine-coated glass-bottomed dishes 16 h later. At 24 h cells were 
